Gregg Orloff PhD
Academic Appointment
- Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
- Senior Lecturer, Department of Biology, Emory University, Atlanta
Education
Degrees
- BS from The Pennsylvania State University
- PhD from Emory University, Atlanta
Research
Publications
-
Videos improve patient understanding of misunderstood chemotherapy terminology.
Cancer Volume: 125 Page(s): 4011 - 4018
11/15/2019 Authors: Pentz RD; Lohani M; Hayban M; Switchenko JM; Dixon MD; DeFeo RJ; Orloff GM; Jani AB; Master VA -
The Multiple Myeloma Research Consortium (MMRC): A Model For Accelerating Development Of Novel Therapies For Multiple Myeloma
Volume: 122
11/15/2013 Authors: Harrison B; Anderson KC; Raje N; Richardson P; Warren D; Chari A; Jagannath S; La L; Berdeja J; Zimlich M -
Serotonin Dysregulation Correlates with Both Bone and Active Disease In Multiple Myeloma
Volume: 116 Page(s): 800 - 800
11/19/2010 Authors: Romano A; Chiechi A; Vetro C; Parrinello N; van Meter A; Orloff G; Patel D; Spira AI; Di Raimondo F; Liotta L -
Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 10 Page(s): 186 - 191
06/01/2010 Authors: Rifkin R; Spitzer G; Orloff G; Mandanas R; McGaughey D; Zhan F; Boehm KA; Asmar L; Beveridge R -
ROLE OF SEROTONIN REGULATION IN OSTEOLYTIC LESIONS OF PATIENTS WITH MULTIPLE MYELOMA
Volume: 95 Page(s): 570 - 570
06/01/2010 Authors: Romano A; Chiechi A; Van Meter A; Orloff G; Patel P; Spira A; Walker C; Di Raimondo F; Petricoin E; Liotta L -
Use of an ex vivo multiplexed signal pathway inhibitor treatment to reveal sensitivity of myeloma and nonmyeloma bone marrow cell populations
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Liotta LA; Romano A; VanMeter A; Orloff GJ; Spira AI; Patel D; Dunning D; Steger L; Petricoin E; Espina VA -
ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells.
Antiviral Res Volume: 85 Page(s): 504 - 511
03/01/2010 Authors: Hsiao N-W; Chen J-W; Yang T-C; Orloff GM; Wu Y-Y; Lai C-H; Lan Y-C; Lin C-W -
Ex Vivo Multiplexed Signal Pathway Inhibitor Treatment Reveals Differential Sensitivity of Myeloma and Non-Myeloma Bone Marrow Cell Populations
Volume: 114 Page(s): 1116 - 1117
11/20/2009 Authors: Espina V; Romano A; VanMeter A; Orloff G; Spira AI; Patel D; Walker C; Petricoin EF; Liotta LA -
A MD3100: SUCCESSFUL MOBILIZATION IN PATIENTS WHO FAIL STANDARD MOBILIZATION WITH GOOD TRANSPLANT OUTCOME AND NO SIGNIFICANT TOXICITY
Volume: 15 Page(s): 42 - 42
02/01/2009 Authors: Kannarkat GT; Beveridge R; Eichna D; Scherer D; Sampl K; Salam A; Sese GB; Lucy NMH; Mintz K; Soubra M -
PEGFILGRASTIM (P) APPEARS TO BE EQUIVALENT TO MULTIPLE DAILY DOSES OF FILGRASTIM (F) TO TREAT NEUTROPENIA POST-AUTOLO-GOUS PERIPHERAL BLOOD STEM CELL TRANSPLANT (PBSCT) IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA: RESULTS OF A RANDOMIZED PHASE II TRIAL
Volume: 14 Page(s): 31 - 32
02/01/2008 Authors: Rifkin R; Beveridge R; Spitzer G; Orloff G; Mandanas R; McGaughey D; Zhan F; Boehm K; Asmar L